Analytical Data
-
Gene name
CD93
- Application
-
Alternative Names
CD93；C1QR1；MXRA4；Complement component C1q receptor
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NPY3
-
Expression Region
24-580aa
-
AA Sequence
ADTEAVVCVGTACYTAHSGKLSAAEAQNHCNQNGGNLATVKSKEEAQHVQ RVLAQLLRREAALTARMSKFWIGLQREKGKCLDPSLPLKGFSWVGGGEDT PYSNWHKELRNSCISKRCVSLLLDLSQPLLPSRLPKWSEGPCGSPGSPGS NIEGFVCKFSFKGMCRPLALGGPGQVTYTTPFQTTSSSLEAVPFASAANV ACGEGDKDETQSHYFLCKEKAPDVFDWGSSGPLCVSPKYGCNFNNGGCHQ DCFEGGDGSFLCGCRPGFRLLDDLVTCASRNPCSSSPCRGGATCVLGPHG KNYTCRCPQGYQLDSSQLDCVDVDECQDSPCAQECVNTPGGFRCECWVGY EPGGPGEGACQDVDECALGRSPCAQGCTNTDGSFHCSCEEGYVLAGEDGT QCQDVDECVGPGGPLCDSLCFNTQGSFHCGCLPGWVLAPNGVSCTMGPVS LGPPSGPPDEEDKGEKEGSTVPRAATASPTRGPEGTPKATPTTSRPSLSS DAPITSAPLKMLAPSGSPGVWREPSIHHATAASGPQEPAGGDSSVATQNN DGTDGQKVDHHHHHH
-
Molecular Weight
59 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CD93, also known as the clustering of differentiation 93, is a type II transmembrane glycoprotein that is predominantly expressed on the surface of endothelial cells and certain immune cells. It has been identified as playing a crucial role in various physiological and pathological processes, such as angiogenesis, inflammation, and immune response modulation. The significance of CD93 has prompted researchers to explore its potential as a therapeutic target and a biomarker for diseases, including cancer and cardiovascular disorders. The recombinant protein forms of CD93 have been developed to study its structural and functional properties, facilitating investigations into its interactions with ligands and other signaling pathways. These studies aim to elucidate the mechanisms by which CD93 influences cell behavior and to determine its role in disease mechanisms. Moreover, the availability of CD93 recombinant proteins can assist in high-throughput screening for small molecules or antibodies that modulate CD93 activity, paving the way for novel therapeutic strategies. Understanding the biology of CD93 at the molecular level can ultimately contribute to the development of targeted therapies that manipulate its functions for clinical benefits.
